2018
DOI: 10.1016/j.bbrc.2018.07.022
|View full text |Cite
|
Sign up to set email alerts
|

Diosgenin inhibited the expression of TAZ in hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(20 citation statements)
references
References 19 publications
0
20
0
Order By: Relevance
“…The compound was found to inhibit TAZ, one of the transcription co-activators in Hippo signalling pathway, which may play a role as an oncogenic factor in the cells. Diosgenin also inhibited the growth and migration of human liver cancer cells (Chen et al 2018). Its widely known glycoside-dioscin exerted rare mechanism of proapoptotic activity by triggering both intrinsic (loss of mitochondrial membrane potential, activation of tBid and Bak proteins) and extrinsic (up-regulation of death ligands and receptors) apoptosis pathways in human leukemia cells.…”
Section: Results Of In Vitro Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…The compound was found to inhibit TAZ, one of the transcription co-activators in Hippo signalling pathway, which may play a role as an oncogenic factor in the cells. Diosgenin also inhibited the growth and migration of human liver cancer cells (Chen et al 2018). Its widely known glycoside-dioscin exerted rare mechanism of proapoptotic activity by triggering both intrinsic (loss of mitochondrial membrane potential, activation of tBid and Bak proteins) and extrinsic (up-regulation of death ligands and receptors) apoptosis pathways in human leukemia cells.…”
Section: Results Of In Vitro Studiesmentioning
confidence: 99%
“…The underlying mechanism included up-regulation of H-Ras and N-Ras proteins, c-Raf phosphorylation and the activation of ERK and p38. Interesting proapoptotic mechanism was recently proposed for a sapogenin-diosgenin by Chen et al (2018). The compound was found to inhibit TAZ, one of the transcription co-activators in Hippo signalling pathway, which may play a role as an oncogenic factor in the cells.…”
Section: Results Of In Vitro Studiesmentioning
confidence: 99%
“…Direct inhibition of the YAP oncoprotein is an anticancer therapeutic strategy (40). A previous study reported that dioscin downregulated the expression of tafazzin, a homolog protein of YAP, in hepatocellular carcinoma; however, alterations in YAP expression were not investigated (41). The present study demonstrated that, compared with the control group, dioscin notably deactivated YAP protein expression by increasing its phosphorylation, and nuclear YAP accumulation was markedly decreased following dioscin treatment.…”
Section: Discussionmentioning
confidence: 41%
“…Di induced cell cycle arrest in different phases in different cancer cells. It was reported that Di could induce G2/M cell cycle arrest in liver cancer cells [21], arrest SCC cells at the sub-G1 phase [22], and impede cell cycle progression in the G0/G1 phase in A549 cells [23]. To determine the antiproliferative mechanisms of Di and P2, the effects of Di and P2 on cell cycle distributions were examined in A549 and PC9 cells.…”
Section: Resultsmentioning
confidence: 99%